nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant endocrine therapy non-initiation and non-persistence in young women with early-stage breast cancer
|
Rosenberg, Shoshana M. |
|
|
197 |
3 |
p. 547-558 |
artikel |
2 |
Axillary ultrasound after neoadjuvant therapy reduces the false-negative rate of sentinel lymph node biopsy in patients with cytologically node-positive breast cancer
|
Liu, Yu |
|
|
197 |
3 |
p. 515-523 |
artikel |
3 |
Changes in the survival of patients with breast cancer: Poland, 2000–2019
|
Caetano dos Santos, Florentino Luciano |
|
|
197 |
3 |
p. 623-631 |
artikel |
4 |
Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancer
|
Shimomura, Akihiko |
|
|
197 |
3 |
p. 593-602 |
artikel |
5 |
Development and validation of genome-wide polygenic risk scores for predicting breast cancer incidence in Japanese females: a population-based case-cohort study
|
Ohbe, Hiroyuki |
|
|
197 |
3 |
p. 661-671 |
artikel |
6 |
Effect of prior treatments on post-CDK 4/6 inhibitor survival in hormone receptor-positive breast cancer
|
Franks, Jeffrey |
|
|
197 |
3 |
p. 673-681 |
artikel |
7 |
Exploring the intersectionality of race/ethnicity with rurality on breast cancer outcomes: SEER analysis, 2000–2016
|
Moore, Justin Xavier |
|
|
197 |
3 |
p. 633-645 |
artikel |
8 |
Factors associated with ductal carcinoma in situ (DCIS) treatment patterns and patient-reported outcomes across a large integrated health network
|
Kim, Hayeon |
|
|
197 |
3 |
p. 683-692 |
artikel |
9 |
Geometric tumor embolic budding characterizes inflammatory breast cancer
|
Modi, Arnav P. |
|
|
197 |
3 |
p. 461-478 |
artikel |
10 |
Mechanistic and thermal characterization of acupuncture for chemotherapy-induced peripheral neuropathy as measured by quantitative sensory testing
|
Zhi, W. Iris |
|
|
197 |
3 |
p. 535-545 |
artikel |
11 |
Neoadjuvant docetaxel, epirubicin, and cyclophosphamide with or without metformin in breast cancer patients with metabolic abnormality: results from the randomized Phase II NeoMET trial
|
Huang, Jiahui |
|
|
197 |
3 |
p. 525-533 |
artikel |
12 |
Ovarian removal and subsequent breast cancer prognosis: a nationwide cohort study
|
Gottschau, Mathilde |
|
|
197 |
3 |
p. 583-591 |
artikel |
13 |
Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II study
|
Xu, Binghe |
|
|
197 |
3 |
p. 489-501 |
artikel |
14 |
Pertuzumab, trastuzumab, and docetaxel for Chinese patients with previously untreated HER2-positive locally recurrent or metastatic breast cancer (PUFFIN): final analysis of a phase III, randomized, double-blind, placebo-controlled study
|
Xu, Binghe |
|
|
197 |
3 |
p. 503-513 |
artikel |
15 |
Prognostic factors and adjuvant systemic therapy for patients with HER2-positive T1N0 breast cancer: evidence from a real-world study with long-term follow-up
|
Gao, Song-lin |
|
|
197 |
3 |
p. 569-582 |
artikel |
16 |
Radiosensitivity is associated with antitumor immunity in estrogen receptor-negative breast cancer
|
Kang, Byung-Hee |
|
|
197 |
3 |
p. 479-488 |
artikel |
17 |
Relationship between tamoxifen and cataracts: a nationwide cohort study of women in South Korea
|
Yoon, Chang Ik |
|
|
197 |
3 |
p. 603-612 |
artikel |
18 |
Risk factors for reduced function in women with a history of breast cancer
|
Stoyles, Nicholas |
|
|
197 |
3 |
p. 613-621 |
artikel |
19 |
Textbook outcomes in DIEP flap breast reconstruction: a Delphi study to establish consensus
|
Shammas, Ronnie L. |
|
|
197 |
3 |
p. 559-568 |
artikel |
20 |
The impact of HIV on non-adherence for tamoxifen among women with breast cancer in South Africa
|
Ayeni, Oluwatosin A. |
|
|
197 |
3 |
p. 647-659 |
artikel |